Rimrock Gold Corp

PINK:RMRK USA Drug Manufacturers - Specialty & Generic
Market Cap
$865.21K
Market Cap Rank
#50937 Global
#15653 in USA
Share Price
$0.00
Change (1 day)
+0.00%
52-Week Range
$0.00 - $0.00
All Time High
$0.00
About

Rimrock Gold Corp., through its subsidiary, focuses on the development and marketing a line of CBD oils, creams, and hemp extracts. The company was incorporated in 2007 and is based in Las Vegas, Nevada.

Rimrock Gold Corp (RMRK) - Net Assets

Latest net assets as of November 2025: $-273.25K USD

Based on the latest financial reports, Rimrock Gold Corp (RMRK) has net assets worth $-273.25K USD as of November 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.79K) and total liabilities ($278.04K). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $-273.25K
% of Total Assets -5705.7%
Annual Growth Rate N/A
5-Year Change N/A
10-Year Change N/A
Growth Volatility 12880.81

Rimrock Gold Corp - Net Assets Trend (2007–2025)

This chart illustrates how Rimrock Gold Corp's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Rimrock Gold Corp (2007–2025)

The table below shows the annual net assets of Rimrock Gold Corp from 2007 to 2025.

Year Net Assets Change
2025-08-31 $-272.37K +31.91%
2024-08-31 $-400.03K -5.88%
2023-08-31 $-377.80K -1.87%
2022-08-31 $-370.87K -3.56%
2021-08-31 $-358.11K +8.16%
2020-08-31 $-389.93K -3.63%
2019-08-31 $-376.27K +59.80%
2018-08-31 $-936.04K +52.87%
2017-08-31 $-1.99 Million -61.06%
2016-08-31 $-1.23 Million -2072.33%
2014-08-31 $-56.77K -101.66%
2013-08-31 $3.42 Million +27224.50%
2012-08-31 $12.52K -97.98%
2011-08-31 $620.92K +905.54%
2010-08-31 $-77.08K +58.81%
2009-08-31 $-187.13K -67.16%
2008-08-31 $-111.95K -98.52%
2007-08-31 $-56.39K --

Equity Component Analysis

This analysis shows how different components contribute to Rimrock Gold Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 553062700.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (August 2025)

Component Amount Percentage
Common Stock $2.88 Million %
Other Components $2.42 Million %
Total Equity $-272.37K 100.00%

Rimrock Gold Corp Competitors by Market Cap

The table below lists competitors of Rimrock Gold Corp ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Rimrock Gold Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from -400,030 to -272,365, a change of 127,665.
  • Net income of 127,665 contributed positively to equity growth.
  • Other factors decreased equity by 0.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income $127.67K +46.87%
Total Change $- %

Book Value vs Market Value Analysis

This analysis compares Rimrock Gold Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-08-31 $-0.23 $0.00 x
2008-08-31 $-0.16 $0.00 x
2009-08-31 $-0.24 $0.00 x
2010-08-31 $-0.05 $0.00 x
2011-08-31 $0.16 $0.00 x
2012-08-31 $0.00 $0.00 x
2013-08-31 $0.16 $0.00 x
2014-08-31 $0.00 $0.00 x
2016-08-31 $0.00 $0.00 x
2017-08-31 $0.00 $0.00 x
2018-08-31 $0.00 $0.00 x
2019-08-31 $0.00 $0.00 x
2020-08-31 $0.00 $0.00 x
2021-08-31 $0.00 $0.00 x
2022-08-31 $0.00 $0.00 x
2023-08-31 $0.00 $0.00 x
2024-08-31 $0.00 $0.00 x
2025-08-31 $0.00 $0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Rimrock Gold Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 0.00%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 0.00%
  • • Asset Turnover: 0.00x
  • • Equity Multiplier: 0.00x
  • Recent ROE (0.00%) is above the historical average (-333.12%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2007 0.00% -150.39% 1.73x 0.00x $-11.31K
2008 0.00% -2173.36% 0.59x 0.00x $-83.19K
2009 0.00% -2878.66% 0.72x 0.00x $-105.50K
2010 0.00% -6186.70% 0.17x 0.00x $-259.68K
2011 -80.27% -117269.18% 0.00x 1.04x $-560.49K
2012 -5880.00% 0.00% 0.00x 12.49x $-737.25K
2013 -35.85% 0.00% 0.00x 1.01x $-1.57 Million
2014 0.00% 0.00% 0.00x 0.00x $-845.32K
2016 0.00% 0.00% 0.00x 0.00x $-356.78K
2017 0.00% 0.00% 0.00x 0.00x $-554.39K
2018 0.00% 0.00% 0.00x 0.00x $1.14 Million
2019 0.00% 856.21% 24.08x 0.00x $418.64K
2020 0.00% -44041.94% 0.02x 0.00x $25.34K
2021 0.00% 337.21% 1.38x 0.00x $55.13K
2022 0.00% -4814.72% 0.02x 0.00x $24.33K
2023 0.00% 0.00% 0.00x 0.00x $7.09K
2024 0.00% 0.00% 0.00x 0.00x $17.78K
2025 0.00% 0.00% 0.00x 0.00x $154.90K

Industry Comparison

This section compares Rimrock Gold Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $548,450,613
  • Average return on equity (ROE) among peers: -450.37%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Rimrock Gold Corp (RMRK) $-273.25K 0.00% N/A $2.92
Ascend Wellness Holdings Inc (AAWH) $142.87 Million -33.75% 5.44x $48.90 Million
AB Science S.A (ABSCF) $10.73 Million -252.65% 3.71x $39.89 Million
Alterola Biotech Inc (ABTI) $4.85K -2005.32% 0.49x $603.58K
Aurora Cannabis Inc (ACB) $2.04 Billion -34.08% 0.34x $199.15 Million
Acreage Holdings Inc (ACRDF) $204.27 Million -30.85% 1.41x $13.48K
Acura Pharmaceuticals Inc (ACUR) $7.90 Million -63.15% 1.15x $13.20K
Agra Ventures Ltd. (AGFAF) $1.51 Million -44.22% 0.06x $298.23K
Allergy Therapeutics plc (AGYTF) $2.07 Million -2084.75% 31.32x $25.30 Million
Aida Pharmaceuticals Inc (AIDA) $6.67 Million 24.51% 2.78x $1.80
Adcock Ingram Holdings Limited (AIHLF) $3.07 Billion 20.55% 0.55x $85.61 Million